Recent News

• 07.30.2026 - Penumbra, Inc. Reports Second Quarter 2026 Financial Results
• 07.23.2026 - Employee Spotlight: Jariell Jones
• 07.22.2026 - THUNDER Study Demonstrates Penumbra’s THUNDERBOLT is Safe and Effective for Stroke Care
• 07.17.2026 - From Algorithms to Personalization: 4 Vascular Surgeons on How Endovascular Advances Are Changing Arterial Care
• 07.09.2026 - Ovarian Vein Embolization with Penumbra Ruby XL Coils for PeVD Related Pain Achieves Complete Resolution of Symptoms
• 07.07.2026 - First Patient Enrolled in Penumbra’s FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
• 06.29.2026 - Why This Big Red Bus Is Bringing Blood Clot Awareness to Communities Across Mississippi
• 06.23.2026 - White Paper — VTE Care at a Crossroads: Today’s Challenges and Tomorrow’s Breakthroughs
• 06.18.2026 - Employee Spotlight: Kywel K. Soe
• 06.15.2026 - Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT

Recent Filings

• 07.30.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.30.2026 - 8-K Current report
• 07.30.2026 - EX-99.1 EX-99.1
• 06.22.2026 - 8-K Current report
• 05.29.2026 - SD Specialized disclosure report
• 05.21.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2026 - 425 Prospectuses and communications, business combinations
• 05.07.2026 - 8-K Current report
• 05.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.06.2026 - 8-K Current report